Melissa Orilall shared on LinkedIn:
“I’m happy to share that I’m starting a new position as Executive Director, Global Financial Operations at Agenus!”
Prior to that she was the Senior Director of the Global Financial Operations at Agenus.
Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company’s mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants (through SaponiQx). Agenus is headquartered in Lexington, MA.
Sources: Melissa Orilall (LinkedIn) and Agenus (LinkedIn)